Comparing the Effect of Different Intracanal Dressing on Failed Root Canal Treated Cases on Periapical Healing
Conditions: Periapical Disease Interventions: Drug: nanocurcumin gel; Drug: Curcumin Gel; Drug: Ciprofloxacin 500 mg +ibuprofen 400mg; Drug: Metapaste [calcium hydroxide paste (control group)] Sponsors: Ain Shams University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 2, 2024 Category: Research Source Type: clinical trials
Rifaximin as a Prophylaxis of Spontaneous Bacterial Peritonitis in Comparison With Ciprofloxacin
Conditions: Spontaneous Bacterial Peritonitis Interventions: Drug: Rifaximin 550Mg Tab; Drug: Ciprofloxacin 750 MG; Diagnostic Test: ascitic fluid sample Sponsors: Ain Shams University Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 31, 2024 Category: Research Source Type: clinical trials
Combination Study of Antibiotics With Enzalutamide (PROMIZE)
Conditions: Metastatic Castration-Resistant Prostate Cancer (mCRPC) Interventions: Drug: Enzalutamide 40mg; Drug: Amoxicillin 500mg; Drug: Metronidazole 400mg; Drug: Vancomycin 125mg; Drug: Ciprofloxacin 500g Sponsors: Institute of Cancer Research, United Kingdom; Prostate Cancer Foundation Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 10, 2023 Category: Research Source Type: clinical trials
FOVOCIP study: a multicenter randomized trial of fosfomycin versus ciprofloxacin for febrile neutropenia in hematologic patients —efficacy and microbiologic safety
DiscussionThis trial will provide evidence of the efficacy of an alternative drug to ciprofloxacin for febrile neutropenia prevention in high-risk hematological patients. The battery of planned microbiological studies will allow us to evaluate prospectively the microbiological safety of both pharmacological strategies in terms of the selection of MRGNB occurring in each arm. In addition, valuable information on the way in which each drug changes the fecal microbiome of the patients throughout the treatment will be generated.Trial registrationClinical trials NCT05311254, Registered on 5 April 2022,https://clinicaltrials.gov...
Source: Trials - October 27, 2023 Category: Research Source Type: clinical trials
Tobramycin Inhalation Solution for Pseudomonas Aeruginosa Eradication in Bronchiectasis
Conditions: Bronchiectasis Adult; Pseudomonas Aeruginosa Infection Interventions: Drug: Tobramycin Inhalant Product; Drug: Ciprofloxacin 750 MG; Drug: Oral ciprofloxacin placebo; Drug: Natural saline inhalation Sponsors: Shanghai Pulmonary Hospital, Shanghai, China Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 20, 2023 Category: Research Source Type: clinical trials
Pivmecillinam with Amoxicillin/Clavulanic acid as step down oral therapy in febrile Urinary Tract Infections caused by ESBL-producing Enterobacterales (PACUTI)
DiscussionIf the combination of pivmecillinam and amoxicillin/clavulanic acid is found to be non-inferior to the control drugs there are potential benefits in terms of tolerability, frequency of interactions, outpatient treatment, side effects, nosocomial infections and drive for further antimicrobial resistance compared to existing drugs.Trial registrationNCT05224401. Registered on February 4, 2022 (Source: Trials)
Source: Trials - September 2, 2023 Category: Research Source Type: clinical trials
Comparing Oral Versus Parenteral Antimicrobial Therapy
Conditions: Endovascular Infection; Bone and Joint Infection; Skin and Soft Tissue Infection; Pulmonary Infection; Gastrointestinal Infection; Genitourinary Infection Interventions: Drug: Amoxicillin, amoxicillin-clavulanate, cefadroxil, cefpodoxime, cefalexin, ciprofloxacin, delafloxacin, doxycycline, levofloxacin, linezolid; Drug: Ampicillin, ampicillin-sulbactam, cefazolin, cefepime, ceftaroline, ceftazidime, ceftazidime-avibactam, dalbavancin, daptomycin, ertapenem Sponsor: West Virginia University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 7, 2023 Category: Research Source Type: clinical trials
Ciprofloxacin Utilization and Adverse Events Occurrence in Community Pharmacy Setting
Condition: Ciprofloxacin Adverse Reaction Intervention: Drug: Ciprofloxacin Tablets Sponsor: Damanhour University Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 23, 2023 Category: Research Source Type: clinical trials
